This is a self-controlled case series (SCCS) study of a cohort of children aged 0–5 years who were born in 2008–2019 and are resident in New Zealand to investigate the association between MMR vaccination and a list of specified conditions.

The GVDN_® is a technical partner with the African COVID-19 Vaccine Safety Surveillance (ACVaSS) project.* Hospital-based sentinel surveillance designed to detect safety signals of rare adverse events of special interest (AESIs) or to evaluate safety signals arising from other sources, following vaccination with COVID-19 vaccines, is being implemented in eight in African Advanced Market Commitment-92 (AMC-92) eligible countries in the Alive (African Leadership in Vaccinology Expertise) Network: Mali, Ghana, Nigeria, Ethiopia, Kenya, Malawi, Mozambique, Eswatini.